American Society of Hematology

banner image

Late-Breaking Abstracts

The final 57th ASH Annual Meeting Program and Late-Breaking Abstracts are now available.

Learn more
banner image

ASH Seeks Founding Editor-in-Chief

ASH is launching a new peer-reviewed, open access journal and is seeking an outstanding individual to serve as its Founding Editor-in-Chief.

Learn more
banner image

57th ASH® Annual Meeting

Register now for the 57th ASH Annual Meeting held December 5-8, 2015 in Orlando Florida.

Learn more
Find a Hematologist

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more
Support Hematology

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more
Join ASH

ASH Membership

Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.

Learn more
  • Statement from ASH President David A. Williams, MD, on Need for Changes to Maintenance of Certification, Comments on Assessment 2020 Report

    As the world’s largest professional society concerned with the causes and treatment of blood disorders, the American Society of Hematology’s membership includes most of the 8,400 internists who hold hematology certificates issued by the American Board of Internal Medicine (ABIM). For more than 14 years, ASH has actively challenged the ABIM’s Maintenance of Certification (MOC) program on a number of fronts, including the lack of evidence that the program’s requirements improve the quality of medical care.

  • Statement from American Society of Hematology President David A. Williams, MD, on Passage of the Bipartisan Budget Act of 2015

    Early this morning, the Senate passed the Bipartisan Budget Act of 2015, a compromise between Congress and the White House that will provide relief from harmful sequestration cuts for the next two years. The American Society of Hematology, the world’s largest professional society concerned with the causes and treatment of blood disorders, applauds the swift action taken by lawmakers in the Senate and the U.S. House of Representatives to raise the budget caps on funding for non-defense discretionary programs, including the National Institutes of Health (NIH).

  • ASH Announces Inaugural Jake Wetchler Foundation ASH Scholar for Pediatric Innovation Recipient

    The American Society of Hematology (ASH), the world’s largest professional organization dedicated to the causes and treatments of blood disorders, today announced that Stephen S. Chung, MD, of Memorial Sloan Kettering Cancer Center will receive the inaugural Jake Wetchler Foundation ASH Scholar Award for Pediatric Innovation for his research on the mechanisms of bone marrow failure syndromes.

  • Study: Sirolimus is Effective, Safe for Children and Young Adults with Treatment-Resistant Autoimmune Blood Conditions

    The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study published online today in Blood, the Journal of the American Society of Hematology. This treatment is particularly effective in children with autoimmune lymphoproliferative syndrome, a chronic genetic disorder characterized by the buildup of white blood cells in the organs.

View all press releases
  • What Hematologist Need to Know about the Medicare Merit-based Incentive Payment System

    In April, 2015, the Medicare Access and CHIP Reauthorization (MACRA) was signed into law by the President. The headline at the time of passage was the end of the Sustainable Growth Rate (SGR) formula that had for so many years mandated large annual Medicare payment cuts to physicians. This calculated approach was replaced with a fixed payment update of 0.5% per year from 2016-2019, followed by flat payment rates for five years. However, MACRA did not just affect the overall payment mechanism – it also created a new pay for performance system for physicians. Many of these elements are similar or identical to the existing pay-for-performance program in Medicare but we will highlight some of the differences.

  • 2015 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait

    ASH is committed to addressing the burden of sickle cell disease (SCD) worldwide and continues to work with various groups in the sickle cell stakeholder community, Congress, the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and other federal agencies to increase research, treatment options, and access to care for patients with SCD. The Society has also taken a number of steps to increase education and awareness about sickle cell trait (SCT).

  • 2015 ASH Advocacy Efforts to Ensure Access to Safe and Effective Hematologic Drugs

    During 2015, ASH made many advocacy efforts to ensure access to safe and effective hematologic drugs.

  • 2015 Physician Payment Advocacy Highlights

    During 2015, ASH made numerous advocacy efforts related to physician payment policies.

View all policy news
View all Hematologist articles